NASDAQ:SLGL

Sol-Gel Technologies - SLGL Stock Forecast, Price & News

$5.88

+0.21 (+3.70%)

(As of 08/5/2022 12:00 AM ET)

Add

Compare

Today's Range: $5.57
▼
$5.97
50-Day Range: $4.10
▼
$6.33
52-Week Range: $3.94
▼
$10.91

Volume: 7,904 shs
Average Volume: 13,531 shs
Market Capitalization: N/A

P/E Ratio: 14.34
Dividend Yield: N/A
Price Target: $18.33

Sol-Gel Technologies MarketRank™ Forecast

Analyst Rating: Buy
3.33 Rating Score
Upside/Downside: 211.7% Upside
$18.33 Price Target
Short Interest: Bearish
1.57% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 2.43
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.49) to $0.28 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.54 out of 5 stars

3.7

Analyst's Opinion

Consensus Rating
Sol-Gel Technologies has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $18.33, Sol-Gel Technologies has a forecasted upside of 211.7% from its current price of $5.88.
Amount of Analyst Coverage
Sol-Gel Technologies has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
1.57% of the float of Sol-Gel Technologies has been sold short.
Short Interest Ratio / Days to Cover
Sol-Gel Technologies has a short interest ratio ("days to cover") of 9.
Change versus previous month
Short interest in Sol-Gel Technologies has recently increased by 1.32%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Sol-Gel Technologies does not currently pay a dividend.
Dividend Growth
Sol-Gel Technologies does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SLGL.

3.6

News and Social Media Coverage

News Sentiment
Sol-Gel Technologies has a news sentiment score of 2.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.33 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Sol-Gel Technologies this week, compared to 0 articles on an average week.
Search Interest
Only 1 people have searched for SLGL on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Sol-Gel Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

N/A

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Sol-Gel Technologies insiders have not sold or bought any company stock.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Sol-Gel Technologies are expected to grow in the coming year, from ($0.49) to $0.28 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Sol-Gel Technologies is 14.34, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 136.11.
Price to Earnings Ratio vs. Sector
The P/E ratio of Sol-Gel Technologies is 14.34, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 105.61.
Price to Book Value per Share Ratio
Sol-Gel Technologies has a P/B Ratio of 2.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Sol-Gel Technologies (NASDAQ:SLGL) Stock

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Sol-Gel Technologies Stock Up 3.8 %

Shares of NASDAQ:SLGL traded up $0.21 during midday trading on Friday, hitting $5.88. The stock had a trading volume of 7,904 shares, compared to its average volume of 13,531. The stock has a 50 day moving average price of $5.13 and a two-hundred day moving average price of $6.38. Sol-Gel Technologies has a 1 year low of $3.94 and a 1 year high of $10.91.

Sol-Gel Technologies (NASDAQ:SLGL - Get Rating) last announced its quarterly earnings data on Friday, May 13th. The company reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.30) by $0.06. Sol-Gel Technologies had a net margin of 28.91% and a return on equity of 19.54%. As a group, equities research analysts predict that Sol-Gel Technologies will post -0.49 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, HC Wainwright increased their target price on shares of Sol-Gel Technologies from $20.00 to $21.00 and gave the company a "buy" rating in a research report on Monday, April 25th.

Receive SLGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sol-Gel Technologies and its competitors with MarketBeat's FREE daily newsletter.

SLGL Stock News Headlines

August 4, 2022 | finance.yahoo.com

Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

June 1, 2022 | finance.yahoo.com

Sol-Gel Technologies to Participate in the 2022 Jefferies Global Healthcare Conference

August 7, 2022 | Paradigm Press (Ad)

US Dollar Replaced By "Biden Bucks"?

A former advisor to the CIA and Pentagon now believes President Biden plans to retire the US dollar we know. And replace it with what he calls 'Biden Bucks'. It is underway.

May 27, 2022 | finance.yahoo.com

Investors in Sol-Gel Technologies (NASDAQ:SLGL) have unfortunately lost 43% over the last year

May 17, 2022 | finance.yahoo.com

Sol-Gel Technologies to Present in Upcoming H.C. Wainwright Global Investment Conference

May 13, 2022 | finance.yahoo.com

Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update

April 25, 2022 | nasdaq.com

Sol-Gel Technologies Says FDA Approves EPSOLAY For Inflammatory Lesions Of Rosacea

April 25, 2022 | seekingalpha.com

Sol-Gel's stock rises as FDA approves Epsolay to treat skin condition rosacea

August 7, 2022 | Legacy Research (Affiliate) (Ad)

“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist)

Has President Biden’s new executive order… Alongside MIT, 77 global Governments, The Gates Foundation, UNICEF, and The Clinton Development Initiative… Ignited a historic $40 trillion transfer of wealth from the middle class, to the rich?

April 14, 2022 | finance.yahoo.com

Sol-Gel Technologies Announces the Commercial Availability of TWYNEO®

April 12, 2022 | finance.yahoo.com

Are Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

March 30, 2022 | finance.yahoo.com

Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments

March 30, 2022 | finance.yahoo.com

Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments

March 29, 2022 | sg.finance.yahoo.com

Sol-Gel Technologies Ltd. (SLGL)

March 25, 2022 | finance.yahoo.com

Sol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American Academy of Dermatology Annual Meeting to be Held March 25-29 in Boston, MA

January 4, 2022 | nasdaq.com

What Type Of Shareholders Own The Most Number of Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Shares?

December 22, 2021 | finance.yahoo.com

Sol-Gel Technologies to Participate in Upcoming LifeSci Partners Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare Conference

December 21, 2021 | finance.yahoo.com

Sol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY®

November 30, 2021 | finance.yahoo.com

Shareholders in Sol-Gel Technologies (NASDAQ:SLGL) have lost 23%, as stock drops 12% this past week

November 11, 2021 | finance.yahoo.com

Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments

November 11, 2021 | finance.yahoo.com

Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments

November 9, 2021 | finance.yahoo.com

Sol-Gel Technologies to Present Live at Jefferies London Healthcare Conference

November 4, 2021 | finance.yahoo.com

Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Million

October 1, 2021 | finance.yahoo.com

Will Sol-Gel Technologies (NASDAQ:SLGL) Spend Its Cash Wisely?

September 22, 2021 | finance.yahoo.com

Sol-Gel Technologies to Present at Upcoming Cantor Virtual Global Healthcare Conference

September 9, 2021 | finance.yahoo.com

Sol-Gel Technologies to Present at Upcoming H.C. Wainwright Global Investment Conference

August 17, 2021 | finance.yahoo.com

What Is The Ownership Structure Like For Sol-Gel Technologies Ltd. (NASDAQ:SLGL)?

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SLGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sol-Gel Technologies and its competitors with MarketBeat's FREE daily newsletter.

SLGL Company Calendar

Last Earnings: 5/13/2022
Today: 8/07/2022
Next Earnings (Estimated): 11/10/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:SLGL
CUSIP: N/A
CIK: 1684693
Web: www.sol-gel.com
Phone: (728) 931-3433
Fax: 972-153-523044444
Employees: 65
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $18.33
High Stock Price Forecast: $21.00
Low Stock Price Forecast: $17.00
Forecasted Upside/Downside: +211.7%
Consensus Rating: Buy
Rating Score (0-4): 3.33
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.41
Trailing P/E Ratio: 14.34
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $3.22 million
Net Margins: 28.91%
Pretax Margin: 5.52%
Return on Equity: 19.54%
Return on Assets: 16.15%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 11.09
Quick Ratio: 11.09

Sales & Book Value

Annual Sales: $31.27 million
Price / Sales: N/A
Cash Flow: $0.20 per share
Price / Cash Flow: 29.24
Book Value: $2.73 per share
Price / Book: 2.15

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 1.41

Key Executives

Dr. Alon Seri-Levy (Age 61)
Co-Founder, CEO & Director
Comp: $567k
Mr. Gilad Mamlok (Age 54)
Chief Financial Officer
Comp: $469k
Mr. Moshe Arkin (Age 69)
Exec. Chairman
Prof. David Avnir
Co-Founder
Dr. Itzik Yosef (Age 46)
Chief Operating Officer
Dr. Karine Neimann (Age 51)
VP of Projects & Planning and Chief Chemist

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SLGL Stock - Frequently Asked Questions

Should I buy or sell Sol-Gel Technologies stock right now?: 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sol-Gel Technologies in the last year. There are currently 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Sol-Gel Technologies stock.
View analyst ratings for Sol-Gel Technologies or view top-rated stocks.
What is Sol-Gel Technologies' stock price forecast for 2022?: 3 Wall Street research analysts have issued 1-year target prices for Sol-Gel Technologies' shares. Their SLGL stock forecasts range from $17.00 to $21.00. On average, they predict Sol-Gel Technologies' share price to reach $18.33 in the next twelve months. This suggests a possible upside of 211.7% from the stock's current price.
View analysts' price targets for Sol-Gel Technologies or view top-rated stocks among Wall Street analysts.
How has Sol-Gel Technologies' stock performed in 2022?: Sol-Gel Technologies' stock was trading at $7.40 at the beginning of the year. Since then, SLGL shares have decreased by 20.5% and is now trading at $5.8809.
View the best growth stocks for 2022 here.
When is Sol-Gel Technologies' next earnings date?: Sol-Gel Technologies is scheduled to release its next quarterly earnings announcement on Thursday, November 10th 2022.
View our earnings forecast for Sol-Gel Technologies.
How were Sol-Gel Technologies' earnings last quarter?: Sol-Gel Technologies Ltd. (NASDAQ:SLGL) released its quarterly earnings data on Friday, May, 13th. The company reported ($0.24) EPS for the quarter, beating analysts' consensus estimates of ($0.30) by $0.06. Sol-Gel Technologies had a trailing twelve-month return on equity of 19.54% and a net margin of 28.91%.

What other stocks do shareholders of Sol-Gel Technologies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Sol-Gel Technologies investors own include CorMedix (CRMD), NVIDIA (NVDA), Advanced Micro Devices (AMD), Flexion Therapeutics (FLXN), Iovance Biotherapeutics (IOVA), Marker Therapeutics (MRKR), Teva Pharmaceutical Industries (TEVA), Viking Therapeutics (VKTX), Verona Pharma (VRNA) and Adaptimmune Therapeutics (ADAP).
When did Sol-Gel Technologies IPO?: (SLGL) raised $60 million in an IPO on Thursday, February 1st 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. Jefferies and BMO Capital Markets acted as the underwriters for the IPO and JMP Securities and Raymond James were co-managers.
What is Sol-Gel Technologies' stock symbol?: Sol-Gel Technologies trades on the NASDAQ under the ticker symbol "SLGL."
How do I buy shares of Sol-Gel Technologies?: Shares of SLGL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Sol-Gel Technologies' stock price today?: One share of SLGL stock can currently be purchased for approximately $5.88.
How many employees does Sol-Gel Technologies have?: Sol-Gel Technologies employs 65 workers across the globe.
How can I contact Sol-Gel Technologies?: Sol-Gel Technologies' mailing address is 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK, NESS ZIONA L3, 7403648. The official website for Sol-Gel Technologies is www.sol-gel.com. The company can be reached via phone at (728) 931-3433, via email at crusso@soleburytrout.com, or via fax at 972-153-523044444.

This page (NASDAQ:SLGL) was last updated on 8/7/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Sol-Gel Technologies - SLGL Stock Forecast, Price & News

Sol-Gel Technologies MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Sol-Gel Technologies (NASDAQ:SLGL) Stock

Sol-Gel Technologies Stock Up 3.8 %

Wall Street Analyst Weigh In

SLGL Stock News Headlines

SLGL Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

SLGL Stock - Frequently Asked Questions

Should I buy or sell Sol-Gel Technologies stock right now?

What is Sol-Gel Technologies' stock price forecast for 2022?

How has Sol-Gel Technologies' stock performed in 2022?

When is Sol-Gel Technologies' next earnings date?

How were Sol-Gel Technologies' earnings last quarter?

What other stocks do shareholders of Sol-Gel Technologies own?

When did Sol-Gel Technologies IPO?

What is Sol-Gel Technologies' stock symbol?

How do I buy shares of Sol-Gel Technologies?

What is Sol-Gel Technologies' stock price today?

How many employees does Sol-Gel Technologies have?

How can I contact Sol-Gel Technologies?

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™